https://orcid.org/0000-0003-1762-5835
References
- Newton JL, Frith J, Powell D, et al. Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren’s syndrome. Ann Rheum Dis. 2012;71(12):1973–1979. doi:10.1136/annrheumdis-2011-201009
- Freeman R. Clinical practice neurogenic orthostatic hypotension. N Engl J Med. 2008;358(6):615–624. doi:10.1056/NEJMcp074189
- Tobón GJ, Pers JO, Devauchelle-Pensec V, Youinou P. Neurological disorders in primary sjögren’s syndrome. Autoimmune Dis. 2012;2012:645967.
- Dupond JL, Gil H, de Wazieres B. Five-year efficacy of intravenous gammaglobulin to treat dysautonomia in Sjögren’s syndrome. Am J Med. 1999;106(1):125.
- Law WG, Thong BY, Umapathi T, Chng HH. Acute pan-dysautonomia: a rare initial presentation of lupus with Sjogren’s syndrome. Lupus. 2006;15(12):899–900. doi:10.1177/0961203306070984
- Barendregt PJ, van den Bent MJ, van Raaij-van den Aarssen VJ, et al. Involvement of the peripheral nervous system in primary Sjögren’s syndrome. Ann Rheum Dis. 2001;60(9):876–881.
- Patel R, Shahane A. The epidemiology of Sjögren’s syndrome. Clin Epidemiol. 2014;6:247–255.
- Sebastian A, Szachowicz A, Wiland P. Classification criteria for secondary Sjögren’s syndrome. Current state of knowledge. Reumatologia. 2019;57(5):277–280. doi:10.5114/reum.2019.89520
- Gharbiya M, Moramarco A, Castori M, et al. Ocular features in joint hypermobility syndrome/ehlers-danlos syndrome hypermobility type: a clinical and in vivo confocal microscopy study. Am J Ophthalmol. 2012;154(3):593–600.e1. doi:10.1016/j.ajo.2012.03.023
- Scully C. Drug effects on salivary glands: dry mouth. Oral Dis. 2003;9(4):165–176. doi:10.1034/j.1601-0825.2003.03967.x
- Stevens S. Schirmer’s test. Community Eye Health. 2011;24(76):45.
- Akpek EK, Amescua G, Farid M, et al. Dry eye syndrome preferred practice pattern®. Ophthalmology. 2019;126(1):P286–P334. doi:10.1016/j.ophtha.2018.10.023
- Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int. 2015;112(5):71–81.
- Senchyna M, Wax MB. Quantitative assessment of tear production: A review of methods and utility in dry eye drug discovery. J Ocul Biol Dis Infor. 2008;1(1):1–6. doi:10.1007/s12177-008-9006-2
- Thieben MJ, Sandroni P, Sletten DM, et al. Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin Proc. 2007;82(3):308–313. doi:10.1016/S0025-6196(11)61027-6
- Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009;3:405–412. doi:10.2147/OPTH.S5555
- Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ. Antinuclear, anticytoplasmic, and anti-Sjogren’s syndrome antigen A (SS-A/Ro) antibodies in female blood donors. Clin Immunol Immunopathol. 1985;36(1):120–128. doi:10.1016/0090-1229(85)90045-5
- Wallman D, Weinberg J, Hohler AD. Ehlers-danlos syndrome and postural tachycardia syndrome: a relationship study. J Neurol Sci. 2014;340(1–2):99–102. doi:10.1016/j.jns.2014.03.002
- Deb A, Morgenshtern K, Culbertson CJ, Wang LB, Hohler AD. A survey-based analysis of symptoms in patients with postural orthostatic tachycardia syndrome. Proc. 2015;28(2):157–159. doi:10.1080/08998280.2015.11929217
- Perez-Roustit S, Nguyen DT, Xerri O, et al. [Ocular manifestations in Ehlers-Danlos syndromes: clinical study of 21 patients]. J Fr Ophtalmol. 2019;42(7):722–729. doi:10.1016/j.jfo.2019.01.005.French.